Business Context and Reporting Period
This Form 8-K Current Report was filed by Phibro Animal Health Corporation on January 23, 2025, covering events occurring on January 21, 2025. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statement data.
Material Changes
The material change reported is the appointment of a new director to the Board of Directors.
- Appointment: Joyce J. Lee was appointed as a Class II director, effective January 21, 2025.
- Independence: The Board determined that Ms. Lee is an independent director.
- Election: Ms. Lee is expected to stand for election by stockholders at the 2027 Annual Meeting of Stockholders.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business performance. Regarding the new appointment:
- Compensation: Ms. Lee will receive the same compensation as other non-employee directors for service on the Board and its committees.
- Indemnification: Ms. Lee has entered into the Corporation's standard director indemnification agreement, requiring indemnification to the fullest extent permitted under Delaware law and advancement of expenses for proceedings where she could be indemnified.
Important Facts for Investor Verification
- Verify the biographical background and potential conflicts of interest for the newly appointed director, Joyce J. Lee.
- Confirm the specific compensation structure for non-employee directors as referenced in the filing.
- Note that the next opportunity for stockholders to vote on Ms. Lee's tenure is the 2027 Annual Meeting.